Literature DB >> 28768682

Quantitative Characterization of Major Hepatic UDP-Glucuronosyltransferase Enzymes in Human Liver Microsomes: Comparison of Two Proteomic Methods and Correlation with Catalytic Activity.

Brahim Achour1, Alyssa Dantonio1, Mark Niosi1, Jonathan J Novak1, John K Fallon1, Jill Barber1, Philip C Smith1, Amin Rostami-Hodjegan1, Theunis C Goosen2.   

Abstract

Quantitative characterization of UDP-glucuronosyltransferase (UGT) enzymes is valuable in glucuronidation reaction phenotyping, predicting metabolic clearance and drug-drug interactions using extrapolation exercises based on pharmacokinetic modeling. Different quantitative proteomic workflows have been employed to quantify UGT enzymes in various systems, with reports indicating large variability in expression, which cannot be explained by interindividual variability alone. To evaluate the effect of methodological differences on end-point UGT abundance quantification, eight UGT enzymes were quantified in 24 matched liver microsomal samples by two laboratories using stable isotope-labeled (SIL) peptides or quantitative concatemer (QconCAT) standard, and measurements were assessed against catalytic activity in seven enzymes (n = 59). There was little agreement between individual abundance levels reported by the two methods; only UGT1A1 showed strong correlation [Spearman rank order correlation (Rs) = 0.73, P < 0.0001; R2 = 0.30; n = 24]. SIL-based abundance measurements correlated well with enzyme activities, with correlations ranging from moderate for UGTs 1A6, 1A9, and 2B15 (Rs = 0.52-0.59, P < 0.0001; R2 = 0.34-0.58; n = 59) to strong correlations for UGTs 1A1, 1A3, 1A4, and 2B7 (Rs = 0.79-0.90, P < 0.0001; R2 = 0.69-0.79). QconCAT-based data revealed generally poor correlation with activity, whereas moderate correlations were shown for UGTs 1A1, 1A3, and 2B7. Spurious abundance-activity correlations were identified in the cases of UGT1A4/2B4 and UGT2B7/2B15, which could be explained by correlations of protein expression between these enzymes. Consistent correlation of UGT abundance with catalytic activity, demonstrated by the SIL-based dataset, suggests that quantitative proteomic data should be validated against catalytic activity whenever possible. In addition, metabolic reaction phenotyping exercises should consider spurious abundance-activity correlations to avoid misleading conclusions.
Copyright © 2017 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28768682     DOI: 10.1124/dmd.117.076703

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  10 in total

1.  Toward a Consensus on Applying Quantitative Liquid Chromatography-Tandem Mass Spectrometry Proteomics in Translational Pharmacology Research: A White Paper.

Authors:  Bhagwat Prasad; Brahim Achour; Per Artursson; Cornelis E C A Hop; Yurong Lai; Philip C Smith; Jill Barber; Jacek R Wisniewski; Daniel Spellman; Yasuo Uchida; Michael A Zientek; Jashvant D Unadkat; Amin Rostami-Hodjegan
Journal:  Clin Pharmacol Ther       Date:  2019-07-26       Impact factor: 6.875

2.  Mechanistic Assessment of Extrahepatic Contributions to Glucuronidation of Integrase Strand Transfer Inhibitors.

Authors:  Stephanie N Liu; Jessica Bo Li Lu; Christy J W Watson; Philip Lazarus; Zeruesenay Desta; Brandon T Gufford
Journal:  Drug Metab Dispos       Date:  2019-02-25       Impact factor: 3.922

3.  Comparative Proteomics Analysis of Human Liver Microsomes and S9 Fractions.

Authors:  Xinwen Wang; Bing He; Jian Shi; Qian Li; Hao-Jie Zhu
Journal:  Drug Metab Dispos       Date:  2019-11-07       Impact factor: 3.922

4.  Determining Allele-Specific Protein Expression (ASPE) Using a Novel Quantitative Concatamer Based Proteomics Method.

Authors:  Jian Shi; Xinwen Wang; Huaijun Zhu; Hui Jiang; Danxin Wang; Alexey Nesvizhskii; Hao-Jie Zhu
Journal:  J Proteome Res       Date:  2018-09-04       Impact factor: 4.466

Review 5.  The Ontogeny of UDP-glucuronosyltransferase Enzymes, Recommendations for Future Profiling Studies and Application Through Physiologically Based Pharmacokinetic Modelling.

Authors:  Justine Badée; Stephen Fowler; Saskia N de Wildt; Abby C Collier; Stephan Schmidt; Neil Parrott
Journal:  Clin Pharmacokinet       Date:  2019-02       Impact factor: 6.447

Review 6.  Mechanisms and the clinical relevance of complex drug-drug interactions.

Authors:  Arthur G Roberts; Morgan E Gibbs
Journal:  Clin Pharmacol       Date:  2018-09-27

7.  A repository of protein abundance data of drug metabolizing enzymes and transporters for applications in physiologically based pharmacokinetic (PBPK) modelling and simulation.

Authors:  Mayur K Ladumor; Aarzoo Thakur; Sheena Sharma; Aravind Rachapally; Sarang Mishra; Priyanka Bobe; V Kameswara Rao; Praneetha Pammi; Hari Kangne; David Levi; Ankit Balhara; Sriram Ghandikota; Anupama Joshi; Vivek Nautiyal; Bhagwat Prasad; Saranjit Singh
Journal:  Sci Rep       Date:  2019-07-04       Impact factor: 4.379

8.  Possible Role of Extracellular Vesicles in Hepatotoxicity of Acetaminophen.

Authors:  Martina Šrajer Gajdošik; Anamarija Kovač Peić; Marija Begić; Petra Grbčić; Kate E Brilliant; Douglas C Hixson; Djuro Josić
Journal:  Int J Mol Sci       Date:  2022-08-09       Impact factor: 6.208

9.  Human variability in isoform-specific UDP-glucuronosyltransferases: markers of acute and chronic exposure, polymorphisms and uncertainty factors.

Authors:  E E J Kasteel; K Darney; N I Kramer; J L C M Dorne; L S Lautz
Journal:  Arch Toxicol       Date:  2020-05-15       Impact factor: 5.153

10.  Quantitative Proteomics of Clinically Relevant Drug-Metabolizing Enzymes and Drug Transporters and Their Intercorrelations in the Human Small Intestine.

Authors:  Narciso Couto; Zubida M Al-Majdoub; Stephanie Gibson; Pamela J Davies; Brahim Achour; Matthew D Harwood; Gordon Carlson; Jill Barber; Amin Rostami-Hodjegan; Geoffrey Warhurst
Journal:  Drug Metab Dispos       Date:  2020-01-20       Impact factor: 3.922

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.